Pura Vida Investments’s Adaptive Biotechnologies ADPT Stock Holding History

Pura Vida Investments’s Portfolio ADPT Stock Details ADPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-155,059	Closed	-$1.04M	–	85
2023 Q2	$1.04M	Buy	+155,059	New	+$1.15M	0.14%	75
2022 Q3	–	Sell	-150,000	Closed	-$1.21M	–	199
2022 Q2	$1.21M	Hold	150,000	–	–	0.07%	160
2022 Q1	$2.08M	Buy	+150,000	New	+$2.36M	0.07%	158
2021 Q4	–	Sell	-255,916	Closed	-$7.84M	–	233
2021 Q3	$8.7M	Sell	255,916 -47,116	-16%	-$1.7M	0.26%	100
2021 Q2	$12.4M	Buy	303,032 +46,338	+18%	+$1.8M	0.39%	60
2021 Q1	$10.3M	Sell	256,694 -43,204	-14%	-$2.34M	0.29%	70
2020 Q4	$17.7M	Buy	299,898 +76,498	+34%	+$3.94M	0.64%	36
2020 Q3	$10.9M	Buy	223,400 +156,700	+235%	+$6.59M	0.56%	37
2020 Q2	$3.23M	Sell	66,700 -128,300	-66%	-$4.68M	0.31%	75
2020 Q1	$5.42M	Buy	195,000 +140,990	+261%	+$3.93M	0.64%	39
2019 Q4	$1.62M	Buy	+54,010	New	+$1.55M	0.14%	86
2019 Q3	–	Sell	-35,000	Closed	-$1.69M	–	92
2019 Q2	$1.69M	Buy	+35,000	New	+$1.55M	0.26%	88

Other funds holding ADPT

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

AAP

Aristotle Atlantic Partners Sarasota, Florida $2.14B AUM 37.01% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

Pura Vida Investments's ADPT Position: Q3 2023 in Review

Pura Vida Investments sold out of Adaptive Biotechnologies (ADPT) in Q3 2023, closing a stake of 155,059 shares — an estimated $1.04M sold.

Pura Vida Investments first reported a position in ADPT in Q2 2019 and held it in 12 quarters. The position peaked at $17.7M in Q4 2020. 190 funds tracked by Wall St. Rank hold ADPT as of Q3 2023.

Pura Vida Investments reported no remaining Adaptive Biotechnologies position as of Q3 2023 after selling out during the quarter.
Pura Vida Investments sold 155,059 Adaptive Biotechnologies shares in Q3 2023, an estimated $1.04M.
Pura Vida Investments first reported a position in Adaptive Biotechnologies in Q2 2019 and held it in 12 quarters.
Pura Vida Investments's Adaptive Biotechnologies position peaked at $17.7M in Q4 2020.
190 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q3 2023.

Based on Pura Vida Investments's 13F filing for Q3 2023, filed 14 Nov 2023.